Canopy Growth (CGC) EBITDA Margin (2019 - 2025)
Canopy Growth (CGC) reported EBITDA Margin of 30.87% for Q4 2025, up 99.0% on a YoY basis from 15.51% in Q4 2024, and down 21.86% sequentially from 25.33% in Q3 2025.
Canopy Growth (CGC) EBITDA Margin (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of EBITDA Margin data on file, last reported at 30.87% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 99.0% year-over-year to 30.87%; the trailing twelve-month figure through Dec 2025 stood at 30.25% (up 4457.0% YoY), and the FY2026 full-year result was 259.8%, up 67.0% from the prior year.
- EBITDA Margin fell to 30.87% in Q4 2025, from 25.33% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 134.36% in Q1 2022 to a low of 1552.6% in Q2 2022.
- A 5-year average of 172.97% and a median of 76.83% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 308879 bps in 2021 and slumped 141479 bps in 2022, its largest moves.
- Tracing CGC's EBITDA Margin over 5 years: stood at 96.73% in 2021, then tumbled by 37 bps to 132.81% in 2022, then surged by 42 bps to 76.83% in 2023, then jumped by 59 bps to 31.86% in 2024, then advanced by 3 bps to 30.87% in 2025.
- Business Quant data shows CGC's EBITDA Margin at 30.87% in Q4 2025, 25.33% in Q3 2025, and 31.36% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.87% |
| Sep 30, 2025 | -25.33% |
| Jun 30, 2025 | -31.36% |
| Dec 31, 2024 | -31.86% |
| Sep 30, 2024 | -72.94% |
| Jun 30, 2024 | -43.96% |
| Mar 31, 2024 | -146.64% |
| Dec 31, 2023 | -76.83% |
| Sep 30, 2023 | -10.07% |
| Jun 30, 2023 | -71.67% |
| Mar 31, 2023 | -468.70% |
| Dec 31, 2022 | -132.81% |
| Sep 30, 2022 | -169.63% |
| Jun 30, 2022 | -1,552.60% |
| Mar 31, 2022 | 134.36% |
| Dec 31, 2021 | -96.73% |
| Sep 30, 2021 | -163.93% |
| Jun 30, 2021 | -137.81% |
| Mar 31, 2021 | -157.10% |
| Dec 31, 2020 | -3,185.53% |